Improving Medication Adherence in Coronary Heart Disease.
dc.contributor.author | Zullig, Leah L | |
dc.contributor.author | Ramos, Katherine | |
dc.contributor.author | Bosworth, Hayden B | |
dc.date.accessioned | 2024-01-31T00:38:03Z | |
dc.date.available | 2024-01-31T00:38:03Z | |
dc.date.issued | 2017-09 | |
dc.description.abstract | Purpose of reviewThe purpose of this review was to synthesize research findings from recently published randomized controlled trials (RCTs) targeting any phase of medication adherence, from initiation to discontinuation, among patients with coronary heart disease (CHD).Recent findingsWe identified successful strategies and promising practices for improving medication adherence among patients diagnosed with CHD. Consistent intervention strategies included the following: (1) facilitating patient-provider communication, (2) using mHealth technologies with emphasis on two-way communication, (3) providing patient education in tandem with lifestyle and behavioral counseling, and (4) providing psychosocial support. Regarding medication adherence phases, all studies examined implementation (i.e., taking medications as prescribed over time) and one also addressed treatment initiation (i.e., beginning a new medication). None identified addressed discontinuation. Studies varied by use of objective, self-report, and a combination of outcome measures with a greater number reporting only subjective measures of adherence. Key findings remained mixed in supporting specific intervention designs or delivery formats. This review addresses available data of promising practices for improving CHD medication adherence. Future studies are needed to examine intervention effectiveness, scalability, and durability of observed outcome effects. | |
dc.identifier | 10.1007/s11886-017-0918-y | |
dc.identifier.issn | 1523-3782 | |
dc.identifier.issn | 1534-3170 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.relation.ispartof | Current cardiology reports | |
dc.relation.isversionof | 10.1007/s11886-017-0918-y | |
dc.rights.uri | ||
dc.subject | Humans | |
dc.subject | Coronary Disease | |
dc.subject | Communication | |
dc.subject | Physician-Patient Relations | |
dc.subject | Patient Education as Topic | |
dc.subject | Randomized Controlled Trials as Topic | |
dc.subject | Medication Adherence | |
dc.title | Improving Medication Adherence in Coronary Heart Disease. | |
dc.type | Journal article | |
duke.contributor.orcid | Zullig, Leah L|0000-0002-6638-409X | |
duke.contributor.orcid | Ramos, Katherine|0000-0002-7584-3040 | |
duke.contributor.orcid | Bosworth, Hayden B|0000-0001-6188-9825 | |
pubs.begin-page | 113 | |
pubs.issue | 11 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Psychiatry & Behavioral Sciences | |
pubs.organisational-group | Medicine, General Internal Medicine | |
pubs.organisational-group | Medicine, Geriatrics | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Center for the Study of Aging and Human Development | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Duke Science & Society | |
pubs.organisational-group | Population Health Sciences | |
pubs.organisational-group | Duke Innovation & Entrepreneurship | |
pubs.organisational-group | Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences | |
pubs.organisational-group | Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology | |
pubs.organisational-group | Duke - Margolis Center For Health Policy | |
pubs.publication-status | Published | |
pubs.volume | 19 |